Search PubMed⌕ Search

Biomedical subjects

A J Ryan

Publications and source records attributed to A J Ryan.

At least 127 records · Page 7Linked to original sources
PubMed1978

Touching.

Explore the source record for details and available documents.

Humans↗
PubMed1978

The metabolism and excretion of curcumin (1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) in the rat.

Curcumin labelled with deuterium and tritium was prepared. Oral and intraperitoneal doses of [3H]curcumin led to the faecal excretion of most of the radioactivity. 2. Intravenous and intraperitoneal doses of [3H]curcumin were well excreted in the bile of cannulated rats. 3. The major biliary metabolites were glucuronides of tetrahydrocurcumin and hexahydrocurcumin. A minor biliary metabolite was dihydroferulic acid together with traces of ferulic acid. Metabolites were identified using chemical ionization mass spectrometry.

Animals↗
PubMed1977

Inhibitors of hepatic mixed function oxidase. 3. Inhibition of hepatic microsomal aniline hydroxylase and aminopyrine demethylase by 2,6- and 2,4-dihydroxyphenyl alkyl ketones and related compounds.

A series of 2,6- and 2,4-dihydroxyphenyl alkyl ketones has been investigated as inhibitors of hepatic microsomal aniline hydroxylase and aminopyrine demethylase activities. Structural alterations in both series did little to enhance the inhibitory activity of the parent compounds 2,6-dihydroxyacetophenone (3) and 2,4-dihydroxyacetophenone (27). In the 2,6 series activity against both microsomal systems varied only over a relatively narrow range, 6-allyloxy-2-hydroxyacetophenone (19) being the most potent inhibitor. In the 2,4 series, activity against aniline hydroxylase was poor or absent in most cases. tthe most potent inhibitor was 5-ethyl-2,4-dihydroxyacetophenone (31). In contrast, high activity against aminopyrine demethylase was frequently displayed in this series, 3,5-dibromo-2,4-dihydroxypropiophenone (36) showing greatest inhibitory potency. The effects of some compounds on hexobarbital sleeping times and zoxazolamine paralysis times in mice were also examined.

Acetophenones↗
PubMed1977

Traumatic injuries: office treatment of strain.

Strain, defined as trauma to a musculotendinous unit, is characterized by pain, muscle spasm, swelling, and loss of range of motion. Conservative treatment consists of rest and elevation of the affected muscle, application of ice and compression, active and passive stretching, and resisted motion exercises. If rupture of muscle and fascia is extensive, surgery may be required. Chronic strain may result from repeated injuries. It is usually treated with rest and administration of an anti-inflammatory agent, such as oxyphenbutazone or a corticosteroid preparation. In the event that this regimen does not provide relief from pain and disability, surgery may be necessary.

Anti-Inflammatory Agents↗